Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Current price $2.00
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Oct 2, 26 |
Daily · Wilder smoothing
| Wedbush |
| downgrade |
| Outperform |
| Neutral |
| Oct 2, 26 | TD Cowen | downgrade | Buy | Hold |
| Oct 2, 26 | BTIG | downgrade | Buy | Neutral |
| Oct 2, 26 | HC Wainwright & Co. | maintain | Buy | Buy |
| Oct 2, 26 | Guggenheim | maintain | Buy | Buy |
| Mar 12, 26 | Wedbush | maintain | Outperform | Outperform |
| Mar 10, 26 | HC Wainwright & Co. | maintain | Buy | Buy |
| Feb 17, 26 | Jefferies | maintain | Buy | Buy |
| May 15, 25 | JMP Securities | maintain | Market Outperform | Market Outperform |
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 24.57 | Oscillator | Buy |
| Stochastic %K (14, 3, 3) | 46.25 | Oscillator | Neutral |
| Williams %R (14) | -42.86 | Oscillator | Neutral |
| MACD (12, 26, 9) | -0.57 (Hist 0.11) | Oscillator | Buy |
| Average Directional Index (14) | 58.21 (+DI 10.9 / -DI 37.1) | Trend | Strong Sell |
| EMA 20 | 2.40 | MA | Strong Sell |
| SMA 20 | 2.25 | MA | Strong Sell |
| EMA 50 | 3.43 | MA | Strong Sell |
| SMA 50 | 4.07 | MA | Strong Sell |
| SMA 200 | 4.81 | MA | Strong Sell |
TTM vs. 5-year historical average (annual ratios)
| Metric | FHTX | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | -2.0x | -4.2x · sector 20.7x | Discount |
| Forward P/E (FY26E) | -2.2x | EPS est. -0.91 | In line |
| Price / Book | -1.7x | 473.1x | Discount |
| Price / Sales | 3.2x | 137.7x | Discount |
| EV / EBITDA | -1.5x | -4.0x | Discount |
| Return on equity | 72.6% | — | Top tier |
| Gross margin | 42.7% | 97.8% | Below hist. |
| Debt / Equity | -0.53 | 91.74 | Conservative |
| Piotroski / Altman Z | 3/9 | Z -4.45 | Distress |
Discounted cash flow model
Stock news · updated daily
NEW YORK, Oct. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Foghorn Therapeutics Inc. ("Foghorn" or the "Company") (NASDAQ: FHTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEW YORK, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Foghorn Therapeutics Inc. (“Foghorn” or the “Company”) (NASDAQ: FHTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NEW YORK, Oct. 15, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Foghorn Therapeutics Inc. ("Foghorn" or the "Company") (NASDAQ: FHTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEW YORK, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Foghorn Therapeutics Inc. (“Foghorn” or the “Company”) (NASDAQ: FHTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
[url="]Schall, Brown and Schwartz[/url] LLP (âSBSâ), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of inv
LOS ANGELES--(BUSINESS WIRE)---- $FHTX--FHTX Investors with $100,000 in Losses Have Opportunity to Join Foghorn Therapeutics Inc. Fraud Investigation with SBS Law.
NEW YORK, Oct. 8, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Foghorn Therapeutics Inc. ("Foghorn" or the "Company") (NASDAQ: FHTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Foghorn Therapeutics Inc. (“Foghorn” or the “Company”) (NASDAQ: FHTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | -0.25 | -0.10 | Beat 59.2% | $16.10M |
| May 7, 2026 | -0.28 | -0.29 | Miss -3.6% | $3.27M |
| Mar 11, 2026 | -0.28 | -0.34 | Miss -21.4% | $9.25M |
| Nov 5, 2025 | -0.31 | -0.25 | Beat 19.4% | $8.15M |
| Aug 5, 2025 | -0.31 | -0.28 | Beat 9.7% | $7.56M |
| May 14, 2025 | -0.30 | -0.30 | Beat 0.0% | $5.95M |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 3 | Oct 5, 2026 | 2026-10-05 16:28:27 | View |
| SC 13G/A | Oct 5, 2026 | 2026-10-05 16:27:26 | View |
| 8-K | Oct 1, 2026 | 2026-10-01 07:01:21 | View |
| 10-Q | Aug 6, 2026 | 2026-08-06 07:03:06 | View |
| 8-K | Aug 6, 2026 | 2026-08-06 07:01:44 | View |
| 4 | Jun 25, 2026 | 2026-06-25 16:06:54 | View |
| 4 | Jun 25, 2026 | 2026-06-25 16:06:03 | View |
| 4 | Jun 25, 2026 | 2026-06-25 16:05:13 | View |
| 4 | Jun 25, 2026 | 2026-06-25 16:04:20 | View |
| 4 | Jun 25, 2026 | 2026-06-25 16:03:35 | View |
Proxy statement (DEF 14A) disclosures
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Oct 1, 26 | Bvf Partners L P/Il | 10 percent owner | 0 | — | |
| Oct 1, 26 | Bvf Partners L P/Il | 10 percent owner | 0 | — | |
| Oct 1, 26 | Bvf Partners L P/Il | 10 percent owner | 0 | — | |
| Oct 1, 26 | Bvf Partners L P/Il | 10 percent owner | 313,925 | — | |
| Oct 1, 26 | Bvf Partners L P/Il | 10 percent owner | 109,394 | — | |
| Oct 1, 26 | Bvf Partners L P/Il | 10 percent owner | 109,394 | — | |
| Jun 24, 26 | Lynch Thomas J. Jr. | director | A-Award | 28,000 @ $4.08 | $114.2K |
| Jun 24, 26 | Duty Stuart | director | A-Award | 28,000 @ $4.08 | $114.2K |